Streetbeat News

Stock Prices

RUN

Analysts have varied opinions on Sunrun (NASDAQ:RUN), with recent ratings showing a mix of bullish and indifferent sentiments. The average 12-month price target has increased by 16.07% to $22.9. Sunrun faces challenges with a revenue decline but shows strong profitability and asset utilization. However, its high debt-to-equity ratio raises concerns.

Portfolio Pulse from Benzinga Insights

August 21, 2024 | 1:00 pm

MGX

In the past three months, four analysts have provided ratings on Metagenomi (NASDAQ:MGX), with a mix of bullish and somewhat bullish sentiments. The average 12-month price target is $12.25, down from a previous $14.75. Analysts have adjusted their ratings and price targets in response to market conditions, with some lowering their targets. Metagenomi, a genetic medicines company, has shown significant revenue growth but lags behind industry peers. The company maintains a strong financial position with effective debt management.

Portfolio Pulse from Benzinga Insights

August 21, 2024 | 1:00 pm

TJX

TJX Companies reported strong Q2 earnings, surpassing expectations with a 13% increase in EPS and a 6% rise in sales. The company raised its fiscal 2025 profit outlook and announced a $360 million investment in Dubai's Brands For Less. TJX shares rose 5.02% premarket.

Portfolio Pulse from Nabaparna Bhattacharya

August 21, 2024 | 12:54 pm

EA

HD

MTB

XEL

The article discusses recent insider sales of shares by executives at Electronic Arts, M&T Bank, Xcel Energy, and Home Depot. Insider sales can indicate concerns about a company's prospects or that the stock is overpriced, but should not be the sole basis for investment decisions.

Portfolio Pulse from Avi Kapoor

August 21, 2024 | 12:52 pm

LLY

NVO

Novo Nordisk and Eli Lilly are competing in the obesity-drug market, but their strategic expansions into other healthcare sectors could drive long-term growth. Eli Lilly has overcome supply chain challenges, while Novo Nordisk faces difficulties. Both stocks show bullish trends, with Eli Lilly technically stronger.

Portfolio Pulse from Surbhi Jain

August 21, 2024 | 12:51 pm

OGEN

Oragenics shares rose following the completion of the filing for its ONP-002 drug, which is set to enter Phase IIa clinical trials for concussed patients.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 12:48 pm

GS

MS

Goldman Sachs warns that upcoming US jobs data may overstate economic weakness, potentially impacting financial markets, including cryptocurrencies. The Bureau of Labor Statistics is set to release revised nonfarm payroll data, which could show slower job growth than initially reported. Morgan Stanley predicts a significant downward revision, possibly reigniting recession fears and affecting risk assets like Bitcoin. Goldman Sachs suggests the revisions may not fully reflect the true state of the job market.

Portfolio Pulse from Murtuza Merchant

August 21, 2024 | 12:46 pm

M

Macy's Inc. reported mixed Q2 2024 earnings with a revenue miss and lowered its annual guidance due to a challenging consumer environment. Sales were down 3.8% year-over-year, and the company plans to close more stores than previously estimated. Macy's stock fell 8.62% in premarket trading.

Portfolio Pulse from Vandana Singh

August 21, 2024 | 12:45 pm

SIRI

Sirius XM shares rose following the announcement of a multi-year agreement with Alex Cooper for exclusive rights to the 'Call Her Daddy' podcast.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 12:44 pm

ARCH

CEIX

Arch Resources and CONSOL Energy have announced a merger agreement, leading to a rise in their stock prices.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 12:43 pm